Related references
Note: Only part of the references are listed.Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)
Keyvan Koushan et al.
CLINICAL OPHTHALMOLOGY (2022)
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Tomoaki Tatsumi et al.
SCIENTIFIC REPORTS (2022)
Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema
Meltem Guzin Altinel et al.
LASERS IN MEDICAL SCIENCE (2021)
Subthreshold Diode Micropulse Laser Combined with Intravitreal Therapy for Macular Edema-A Systematized Review and Critical Approach
Maciej Gawecki
JOURNAL OF CLINICAL MEDICINE (2021)
Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Lesley A. Everett et al.
CURRENT DIABETES REPORTS (2021)
Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up
Leila El Matri et al.
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)
Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial)
Alicia Pareja-Rios et al.
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)
Aflibercept plus micropulse laser versus aflibercept monotherapy for diabetic macular edema: 1-year results of a randomized clinical trial
Mahmoud Alaa Abouhussein et al.
INTERNATIONAL OPHTHALMOLOGY (2020)
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Olga Furashova et al.
BMC OPHTHALMOLOGY (2020)
Anatomical and functional outcomes of subthreshold micropulse laser versus intravitreal ranibizumab injection in treatment of diabetic macular edema
Amr Abdelrahman et al.
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS (2020)
Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial
Hatice Selen Kanar et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2020)
Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
You-Xin Chen et al.
CLINICAL OPHTHALMOLOGY (2020)
Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema
Abeer M. Khattab et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema
Keiji Inagaki et al.
SCIENTIFIC REPORTS (2019)
Analysis of Anti-Vascular Endothelial Growth Factor Injection Claims Data in US Medicare Part B Beneficiaries From 2012 to 2015
Sean T. Berkowitz et al.
JAMA OPHTHALMOLOGY (2019)
Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema
Mohammadreza Akhlaghi et al.
JOURNAL OF CURRENT OPHTHALMOLOGY (2019)
Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Durga S. Borkar et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Assessing patient acceptance of laser pretreatment to reduce injection burden in diabetic macular edema: a large scale postal survey
Dana Ahnood et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2018)
Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema
Elad Moisseiev et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2018)
Diabetic Retinopathy: Pathophysiology and Treatments
Wei Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema
Masafumi Hamada et al.
JOURNAL OF OPHTHALMOLOGY (2018)
Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema
Ahmed Hosni Abd Elhamid
OPEN OPHTHALMOLOGY JOURNAL (2017)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
Sobha Sivaprasad et al.
CLINICAL OPHTHALMOLOGY (2016)
Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula
Daniel Lavinsky et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
The REVEAL Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema
Tatsuro Ishibashi et al.
OPHTHALMOLOGY (2015)
LASER RESENSITIZATION OF MEDICALLY UNRESPONSIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Efficacy and Implications
Jeffrey K. Luttrull et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema: The RESTORE Extension Study
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
Laser Treatment for Diabetic Macular Edema in the 21st Century
Pedro Romero-Aroca et al.
CURRENT DIABETES REVIEWS (2014)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
LONG-TERM SAFETY, HIGH-RESOLUTION IMAGING, AND TISSUE TEMPERATURE MODELING OF SUBVISIBLE DIODE MICROPULSE PHOTOCOAGULATION FOR RETINOVASCULAR MACULAR EDEMA
Jeffrey K. Luttrull et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Non-damaging Retinal Phototherapy: Dynamic Range of Heat Shock Protein Expression
Christopher Sramek et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2010)
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2009)
Share Paper
